HU9904026A3 - Use of sibutramine analogues to prevent the development of diabetes - Google Patents

Use of sibutramine analogues to prevent the development of diabetes

Info

Publication number
HU9904026A3
HU9904026A3 HU9904026A HU9904026A HU9904026A3 HU 9904026 A3 HU9904026 A3 HU 9904026A3 HU 9904026 A HU9904026 A HU 9904026A HU 9904026 A HU9904026 A HU 9904026A HU 9904026 A3 HU9904026 A3 HU 9904026A3
Authority
HU
Hungary
Prior art keywords
diabetes
development
prevent
use
sibutramine
Prior art date
Application number
HU9904026A
Other versions
HU9904026A2 (en
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB9619757.9A priority Critical patent/GB9619757D0/en
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of HU9904026A2 publication Critical patent/HU9904026A2/en
Publication of HU9904026A3 publication Critical patent/HU9904026A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/866Diabetes
HU9904026A 1996-09-21 1997-09-15 Use of sibutramine analogues to prevent the development of diabetes HU9904026A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB9619757.9A GB9619757D0 (en) 1996-09-21 1996-09-21 Chemical process

Publications (2)

Publication Number Publication Date
HU9904026A2 HU9904026A2 (en) 2000-05-28
HU9904026A3 true HU9904026A3 (en) 2000-07-28

Family

ID=10800326

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904026A HU9904026A3 (en) 1996-09-21 1997-09-15 Use of sibutramine analogues to prevent the development of diabetes

Country Status (25)

Country Link
US (3) US6174925B1 (en)
EP (1) EP0927028A1 (en)
JP (1) JP2001503737A (en)
KR (1) KR20000048501A (en)
CN (1) CN1237905A (en)
AU (1) AU724488B2 (en)
BG (1) BG64473B1 (en)
BR (1) BR9711517A (en)
CA (1) CA2266401C (en)
CZ (1) CZ93699A3 (en)
GB (1) GB9619757D0 (en)
HR (1) HRP970505A2 (en)
HU (1) HU9904026A3 (en)
ID (1) ID18320A (en)
IL (1) IL128850A (en)
NO (1) NO991358L (en)
NZ (1) NZ334580A (en)
PL (1) PL332305A1 (en)
RU (1) RU2245709C2 (en)
SK (1) SK31999A3 (en)
TR (1) TR199900618T2 (en)
TW (1) TW580385B (en)
UA (1) UA64726C2 (en)
WO (1) WO1998011884A1 (en)
ZA (1) ZA9708450B (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619757D0 (en) * 1996-09-21 1996-11-06 Knoll Ag Chemical process
JP2000080047A (en) * 1998-06-30 2000-03-21 Takeda Chem Ind Ltd Medicine
ES2255316T3 (en) * 1998-06-30 2006-06-16 Takeda Pharmaceutical Company Limited pharmaceutical composition for the treatment of diabetes.
US6974838B2 (en) * 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US6339106B1 (en) 1999-08-11 2002-01-15 Sepracor, Inc. Methods and compositions for the treatment and prevention of sexual dysfunction
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6331571B1 (en) 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
AR023700A1 (en) * 1998-11-12 2002-09-04 Smithkline Beecham Plc A process for preparing a pharmaceutical composition comprising an insulin sensitizer
BR9915285A (en) * 1998-11-12 2001-08-07 Smithkline Beecham Plc Pharmaceutical composition for modified release of an insulin sensitizer and another antidiabetic agent
US6696495B2 (en) 1998-12-02 2004-02-24 Snowden Pharmaceuticals, Llc Treatment of disorders secondary to organic impairments
US6323242B1 (en) 1998-12-02 2001-11-27 Peter Sterling Mueller Treatment of disorders secondary to organic impairments
US6552087B1 (en) 1999-03-19 2003-04-22 Abbott Gmbh & Co. Kg Therapeutic agent comprising (+)-sibutramine
US6723717B1 (en) 1999-06-01 2004-04-20 The University Of Texas Southwestern Medical Center Sulfur-containing thyroxane derivatives and their use as hair growth promotors
US6680344B1 (en) 1999-06-01 2004-01-20 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylmethane derivatives
WO2000072810A1 (en) 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Method of treating hair loss using sulfonyl thyromimetic compounds
WO2002083631A1 (en) * 2001-04-13 2002-10-24 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
US8911781B2 (en) 2002-06-17 2014-12-16 Inventia Healthcare Private Limited Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides
NZ538966A (en) * 2002-10-05 2006-11-30 Hanmi Pharm Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
PE20050335A1 (en) * 2003-08-07 2005-06-01 Sb Pharmco Inc Oral dosage form comprising 5- [4- [2- (N-methyl-N- (2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione and procedure for preparing
GB0318824D0 (en) * 2003-08-11 2003-09-10 Glaxo Group Ltd Novel composition
MXPA06004639A (en) 2003-10-31 2006-06-27 Takeda Pharmaceutical Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester.
KR100627687B1 (en) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 Composition containing sibutramine free base and manufacturing method thereof
AU2007205114B2 (en) * 2006-01-06 2012-11-08 Sunovion Pharmaceuticals Inc. Cycloalkylamines as monoamine reuptake inhibitors
CA2663254C (en) 2006-09-15 2016-04-19 Reviva Pharmaceuticals, Inc. Synthesis, methods of using, and compositions of cycloalkylmethylamines
KR100812538B1 (en) * 2006-10-23 2008-03-11 한올제약주식회사 Controlled release complex formulation comprising metformin and glimepiride
AU2007322477A1 (en) * 2006-11-22 2008-05-29 Sk Chemicals Co., Ltd. Inclusion complex of sibutramine and beta-cyclodextrin
JP5649825B2 (en) 2007-01-31 2015-01-07 デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド Stabilized p53 peptides and methods of use thereof
KR101525754B1 (en) 2007-03-28 2015-06-09 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Stitched polypeptides
US8604244B2 (en) 2010-07-02 2013-12-10 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
CA2807685A1 (en) 2010-08-13 2012-02-16 Aileron Therapeutics, Inc. P53 derived peptidomimetic macrocycle
MX358886B (en) 2011-10-18 2018-08-31 Aileron Therapeutics Inc Peptidomimetic macrocyles.
BR112014016122A8 (en) 2011-12-30 2017-07-04 Reviva Pharmaceuticals Inc compound and pharmaceutical composition
WO2013123267A1 (en) 2012-02-15 2013-08-22 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
RU2642299C2 (en) 2012-02-15 2018-01-24 Эйлерон Терапьютикс, Инк. p53 PEPTIDOMIMETIC MACROCYCLES
CA2887285A1 (en) 2012-11-01 2014-05-08 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
MX2017003797A (en) 2014-09-24 2017-06-15 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof.
JP2018516844A (en) 2015-03-20 2018-06-28 エルロン・セラピューティクス・インコーポレイテッドAileron Therapeutics,Inc. Peptidomimetic macrocycles and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment
JP2675573B2 (en) * 1988-03-31 1997-11-12 科研製薬株式会社 Brain function improver
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
WO1995010292A1 (en) 1993-10-14 1995-04-20 Biomedica California, Inc. Diabetes treatment and prophylaxis
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
GB9619757D0 (en) * 1996-09-21 1996-11-06 Knoll Ag Chemical process

Also Published As

Publication number Publication date
US6174925B1 (en) 2001-01-16
CN1237905A (en) 1999-12-08
NZ334580A (en) 2000-09-29
ZA9708450B (en) 1999-03-19
BR9711517A (en) 1999-08-24
IL128850A (en) 2003-07-31
NO991358D0 (en) 1999-03-19
GB9619757D0 (en) 1996-11-06
IL128850D0 (en) 2000-01-31
HU9904026A2 (en) 2000-05-28
NO991358L (en) 1999-03-19
RU2245709C2 (en) 2005-02-10
CZ93699A3 (en) 1999-08-11
JP2001503737A (en) 2001-03-21
HRP970505A2 (en) 1998-08-31
US20040077730A1 (en) 2004-04-22
UA64726C2 (en) 2000-08-15
CA2266401A1 (en) 1998-03-26
PL332305A1 (en) 1999-08-30
TW580385B (en) 2004-03-21
ID18320A (en) 1998-03-26
SK31999A3 (en) 1999-12-10
AU724488B2 (en) 2000-09-21
KR20000048501A (en) 2000-07-25
CA2266401C (en) 2007-01-30
EP0927028A1 (en) 1999-07-07
TR199900618T2 (en) 1999-06-21
BG64473B1 (en) 2005-04-30
US6617360B1 (en) 2003-09-09
BG103277A (en) 2000-01-31
AU4774097A (en) 1998-04-14
WO1998011884A1 (en) 1998-03-26

Similar Documents

Publication Publication Date Title
DE69810497D1 (en) Reconstruction of the pelvic muscular
HK1012192A1 (en) Modified primers
EP1039920A4 (en) Fatty acid-acylated insulin analogs
DE69330211D1 (en) Tampone importer
AU2493395A (en) Velcro attachment
IL113372D0 (en) Insole
ZA9801162B (en) Diamond-containing body
EP0747006A4 (en) Lancet assembly
ZA9710182B (en) Use of GLP-1 peptides.
HK1012736A1 (en) Extended clock termostat
DE69939950D1 (en) Use of neuregulin to influence the heart muscular function
HK1033463A1 (en) 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
AT214057T (en) Triazolic compounds and their use as dopamin-d 3-ligands
GB9508077D0 (en) Grommet
RU2001118855A (en) Analogues glp-1
DE69813257D1 (en) Self-comprehensive breathing unit
HK1041531A1 (en) Processor
EP0751767A4 (en) Therapeutic guanidines
GB9619462D0 (en) Improvements relating to lancet devices
PL329521A1 (en) Fungicidal mixture
HK1034909A1 (en) Novel fatty analogues for the treatment of diabetes
EP0927917A4 (en) Watch
DE69809726D1 (en) Substituted analogs of indol-3-carbinol and diindolmethane as antiestrogen
DE19581680T1 (en) Strap attachable to the body
DK0975595T3 (en) cocaine analogs

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees